The largest database of trusted experimental protocols

16 protocols using fcs hi

1

NSG Mice Xenograft and WAS Mice Comparison

Check if the same lab product or an alternative is used in the 5 most similar protocols
Housing and care of the animals were in accordance with a protocol approved by the Institutional Animal Care and Use Committee. Eight- to 12-week-old female NOD/LtSz-IL2R γc (NSG) mice (Jackson Lab, Sacramento, CA; strain no. 005557) were used for human CD34+ transplantation studies. Twenty-four hours prior to transplantation, mice were injected intraperitoneally with 35 mg/kg busulfan (BUSULFEX; PDL BioPharma, Redwood City, CA). Twelve to 13 weeks post-transplantation, NSG mice were sacrificed and bone marrow cells were collected from tibias and femurs in Dulbecco’s phosphate-buffered saline (DPBS) (Corning; CellGro, Herndon, VA; cat. no. 21-013-CV), supplemented with 2% heat inactivated fetal calf serum (HI-FCS) (Thermo Scientific; HyClone, Logan, UT; cat. no. SH30396.03). Six- to 8-week-old female WAS–/– and male WAS mice derived on a C57Bl/6 strain as described previously41 (link) were used to compare strength of WASp expression using different promoters.
+ Open protocol
+ Expand
2

PBMC Isolation and Immune Stimulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood mononuclear cells (PBMCs) were separated by density gradient over Ficoll-Paque (GE Healthcare) as previously described (36 (link)). PBMCs from patients with AP and AAH and corresponding controls were cryopreserved in heat inactivated fetal bovine serum (HI-FCS [ThermoFisher Scientific]), 10% dimethyl sulfide (DMSO [Santa Cruz Biotechnology]). All other experiments used freshly isolated PBMCs with no cryopreservation. Viability of all PBMCs were assessed prior to all experiments using trypan blue (Sigma Aldrich) and only those with viability over 70% for cryopreserved samples and 90% for fresh samples, were included. Cells were seeded at 1 million per mL in RPMI 1640 containing L-glutamine (Lonza), penicillin/streptomycin (Sigma Aldrich), and 10% HI-FCS. PBMCs were stimulated with 20 ng/mL lipopolysaccharide from Escherichia coli O55:B5 (LPS [Sigma-Aldrich]), 10 μg/mL polyinosilic:polycytidylic acid (poly I:C [Sigma-Aldrich]), 100 ng/mL flagellin from Salmonella typhimurium (Source BioScience), 1 μg/mL high mobility group box 1 protein (HMGB1 [Sigma-Aldrich]), 1,000 units/mL interferon alpha (IFNα [Peprotech]) or 50 ng/mL interleukin 1 alpha (IL-1α [R&D Systems]) for 3 or 24 h in 12 well plates, with 1 mL per well. Monocytes were magnetically isolated using the Pan monocyte isolation kit (Miltenyi Biotec) according to the manufacturer's instructions.
+ Open protocol
+ Expand
3

Preosteoblasts Proliferation on 3D Printed PLC+β-TCP

Check if the same lab product or an alternative is used in the 5 most similar protocols
The MC3T3-E1 preosteoblasts were plated at a density of 5000 cells/cm2 onto the sterilised 3D printed PLC+β-TCP 20% substrates which were contained in 48 well culture plates (Euroclone, SpA, Milano, Italy). The cells were grown for three days to an 80% confluence in α-MEM (Life Technologies, Monza, Italy) and supplemented with 10% HIFCS (Life Technologies, Monza, Italy), penicillin, and streptomycin (Sigma Aldrich, Milan, Italy). The control cultures were produced by growing cells on culture plates as substrates. Then, the cells were incubated with a CellTiter 96 Aqueous One Solution Reagent (Promega Italia Srl, Milan, Italy) for 2 h in a humidified 5% CO2 atmosphere. The coloured formazan was measured by reading the absorbance at 490 nm using a Tecan fluorometer (Tecan Italia Srl, Cernusco Sul Naviglio, Milan, Italy).
+ Open protocol
+ Expand
4

Mouse Osteoblast Cell Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
The MC3T3-E1 cell line utilized in the current study (mouse calvarian pre-osteoblasts), (ATCC, LGC Standards S.r.L Milano, Italy) were grown in Minimum Essential Medium Eagle (αMEM) (Life Technologies Milano, Italy) supplemented with 10% heat inactivated fetal calf serum (HI-FCS) (Life Technologies Milano, Italy) penicillin (100 U/ml), and streptomycin (50 μg/ml) (Life Technologies Milano, Italy).
+ Open protocol
+ Expand
5

Osteoblast Attachment and ECM Analysis on 3D Printed Scaffolds

Check if the same lab product or an alternative is used in the 5 most similar protocols
The MC3T3-E1 pre-osteoblasts were placed at a density of 5000 cells/cm2 into 12 well culture plates (Euroclone, SpA, Milano, Italy) and onto the previously sterilised 3D printed PCL+β-TCP 20% substrates. The cells were grown for four days in a minimum essential medium (α-MEM; Life Technologies, Monza, Italy) which was supplemented with 10% heat-inactivated fetal calf serum (HIFCS) (Life Technologies, Monza, Italy), penicillin, and streptomycin (Sigma Aldrich, Milano, Italy). Control cultures were produced by growing the cells on culture plates as substrates.
Then, all cultures were washed three times with phosphate-buffered saline (PBS) 0.1 M, pH 7.4 and fixed in 4% paraformaldehyde (PFA) which was diluted in PBS for 20 min at room temperature. The cultures were then washed three times with PBS, and the cells were stained with haematoxylin (5 min) and eosin (30 s). Following Dellinger et al. [43 (link)], 5% toluidine blue (5 s) was used to point out the extracellular matrix (ECM). After washing with tap water, the substrates were mounted on slides and imaged using a light microscope (Axiophot, Zeiss, Oberkochen, Germany). Image analysis was performed using NIH ImageJ software [44 (link)].
+ Open protocol
+ Expand
6

Mouse Calvaria Pre-Osteoblast Cell Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
The MC3T3-E1 cell line (mouse calvaria pre-osteoblasts) (ATCC, LGC Standards S.r.L Milano, Italy) was utilised in the current study. Cells were grown in minimum essential medium Eagle (αMEM) (Life Technologies, Milano, Italy) supplemented with 10% heat-inactivated fetal calf serum (HI-FCS) (Life Technologies, Milano, Italy), penicillin (100 U/mL), and streptomycin (50 µg/mL) (Life Technologies, Milano, Italy). Cells were detached using 0.25% trypsin for 2 min at room temperature and plated for each experimental protocol as below specified. The culture medium was replaced every 3 days.
+ Open protocol
+ Expand
7

ARPE-19 and NHDF Fibroblast Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
ARPE-19 cells (CRL-2302, ATCC) and neonatal NHDF fibroblasts (CC-2509, Lonza) were maintained and propagated in DMEM:F12 with L-glutamine (Biowhittaker) and MEM (Life Technologies) respectively, containing 10% heat-inactivated FCS (HI-FCS; Life Technologies) and 0.04% gentamicine. All infection experiments were done in 24-well plates (Costar).
+ Open protocol
+ Expand
8

Differentiation of iPSCs into Endothelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Differentiation was initiated with B2M/CIITA/ rhCD47 tg hiPSC at 60% confluency, and medium was changed to RPMI-1640 containing 2% B-27 minus insulin (both Gibco) and 5 µM CHIR-99021 (Selleckchem). On day 2, the medium was changed to reduced medium: RPMI-1640 containing 2% B-27 minus insulin (Gibco) and 2 µM CHIR-99021 (Selleckchem). From days 4–7, cells were cultured in RPMI-1640 EC medium of RPMI-1640 containing 2% B-27 minus insulin plus 50 ng/ml human VEGF, 10 ng/ml human FGFb; R&D Systems), 10 µM Y-27632 (Sigma-Aldrich), and 1 µM SB 431542 (Sigma-Aldrich). Endothelial cell clusters were visible from day 7 and cells were maintained in Endothelial Cell Basal Medium 2 (PromoCell) plus 10% FCS hi (Gibco), 1% pen/strep, 25 ng/ml VEGF, 2 ng/ml FGFb, 10 µM Y-27632 (Sigma-Aldrich), and 1 µM SB 431542 (Sigma-Aldrich). The differentiation process was completed after 14 d and undifferentiated cells detached during the differentiation process. TrypLE Express (Gibco) was used for passaging the cells 1:3 every 3–4 d.
+ Open protocol
+ Expand
9

Differentiation of Macrophages from PBMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs were isolated by Ficoll separation from fresh blood and resuspended in RPMI-1640 with 10% FCS hi and 1% pen/strep (all from Gibco). Cells were plated in 24-well plates at a concentration of 106 cells/ml and 10 ng/ml rhesus M-CSF (Biorhyt). Medium was changed every second day until day 6. Macrophages were stimulated from day 6 with 1 µg/ml rhesus IL-2 (MyBioSource) for 24 h before the cells were used for assays.
+ Open protocol
+ Expand
10

Macrophage Differentiation from PBMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs were isolated by Ficoll separation from fresh blood and resuspended in RPMI 1640 with 10% heat-inactivated FCS hi and 1% penicillin–streptomycin (all Gibco). Cells were plated in 24-well plates at a concentration of 1 × 106 cells per milliliter, and 10 ng ml−1 rhesus M-CSF (Biorbyt) was added. Media was changed every other day until day 6. Macrophages were stimulated from day 6 with 1 μg ml−1 rhesus IL-2 (MyBiosource) for 24 h before the cells were used.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!